Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1Anxiety Disorders 1

Interventions

Surveys and Questionnaires 4Therapeutics 2Psilocybin 2Ketamine 2Ultraviolet Therapy 1Self-Help Groups 1Relaxation Therapy 1Psychotherapy 1Psychosocial Intervention 1Propranolol 1Oxygen 1Nitrous Oxide 1Niacin 1N-Methyl-3,4-methylenedioxyamphetamine 1Minocycline 1Midazolam 1Melatonin 1Interviews as Topic 1Imagery, Psychotherapy 1Hormones 1Exercise Test 1Early Intervention, Educational 1Donepezil 1Dehydroepiandrosterone 1Counseling 1Cognitive Behavioral Therapy 1Cannabidiol 1Autogenic Training 1Anesthesia, Local 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Anxiety Disorders × N-Methyl-3,4-methylenedioxyamphetamine × Clear all
NCT00252174 2017-11-14

MDMA-assisted Therapy in People With Anxiety Related to Advanced Stage Cancer

Brigham and Women's Hospital

Phase 2 Terminated
2 enrolled 6 charts

Anxiety Disorders, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡